COVID-19 UPDATE Facts & Figures - 02/09/2021

In Kürze

A research published in The Lancet found that the Delta variant doubles the risk of hospitalisation com-pared to the Alpha variant. A large-scale study by researchers from the University of Oxford has found that the risk of rare blood clotting after receiving first doses of AstraZeneca or Pfizer vaccines is far lower that from the virus.


  • September 01: 647,105 7-day average new cases, compared to 659,516 a week ago and 599,815 a month ago.
    Now confirmed 218,297,310 cases worldwide vs 213,767,576 cases last week.
  • 4,525,907 people have died (2.1% of confirmed cases) and 194,287,167 have recovered (89%).
  • Europe: 57,368,305 cases; 7-day avg growth of 142,942 vs 145,105 a week ago and 125,321 a month ago.
  • USA: 39,396,156 cases; 7-day avg growth of 167,583 vs 155,753 a week ago and 85,459 a month ago.
  • Vaccines: around 5.38 billion doses have been administered globally, of which 371 million in the USA and 533 million
    in the EU. 113 vaccines are in clinical evaluation and 184 vaccines are in preclinical evaluation.
COVID-19 UPDATE Facts & Figures 02/09/2021

© Generali Investments, alle Rechte vorbehalten. Diese Website wird von Generali Investments zur Verfügung gestellt und gilt als Marketingkommunikation und Finanzwerbung für die Produkte und Dienstleistungen der folgenden Unternehmen der Generali Gruppe: Generali Asset Management S.p.A. Società di gestione del risparmio und Generali Investments Luxembourg S.A. (im Folgenden gemeinsam Generali Investments). Darüber hinaus kann die Website Marketingkommunikation und Finanzwerbung für Produkte und Dienstleistungen von Unternehmen enthalten, die Teil der von Generali Asset Management S.p.A. Società di gestione del risparmio koordinierten Multiboutique-Plattform sind, insbesondere von Infranity, Sycomore Asset Management, Aperture Investors LLC, Plenisfer Investments SGR, Lumyna Investments, Sosteneo Infrastructure Partners SGR und Generali Real Estate S.p.A. Società di Gestione del Risparmio